(Total Views: 149)
Posted On: 01/03/2022 11:56:31 AM
Post# of 25481
$SPRC SciSparc Provides Updates Upon Conclusion of 2021
TEL AVIV, Israel, Dec. 29, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"
, today provides updates regarding its activities in 2021.
https://finance.yahoo.com/news/scisparc-provi...00681.html
TEL AVIV, Israel, Dec. 29, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "Company" or "SciSparc"
, today provides updates regarding its activities in 2021. https://finance.yahoo.com/news/scisparc-provi...00681.html
(0)
(0)
